The latest biotech news

News and Trends 18 Apr 2024

Biotech under surveillance: The global impact of the WuXi AppTec controversy

Delve into the ongoing controversy involving the Chinese company WuXi AppTec and the possible impact on U.S. national security measures.

April 18, 2024 - 7 minutesmins - By Jules Adam

News and Trends 1 Feb 2024

Can gene therapy be the key to restoring hearing loss?

Explore gene therapy’s success in treating genetic hearing loss as a child regains hearing at the Children’s Hospital of Philadelphia.

February 1, 2024 - 7 minutesmins - By Roohi Mariam Peter

News and Trends 18 Jan 2024

2024 J.P. Morgan Healthcare Conference: key takeaways from the largest biotech gathering of the year

Here are some of the key takeaways from the JPM Healthcare Conference that lay the groundwork for what we can expect in 2024.

January 18, 2024 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 12 Jan 2024

AI and a brain organoid: can this combo take on supercomputers?

Explore the groundbreaking fusion of brain organoids and AI in the creation of Brainoware, the world’s first biohybrid computer.

January 12, 2024 - 5 minutesmins - By Roohi Mariam Peter

News and Trends 8 Jan 2024

Is the biotech industry poised for recovery in 2024?

The past few years have been challenging for the industry but 2024 might be the year marking the biotech recovery.

January 8, 2024 - 5 minutesmins - By Jules Adam

News and Trends 21 Dec 2023

The big pharma race against deadly RSV steps up in 2023

GSK and Pfizer received FDA approval for their RSV vaccines in 2023. Now, AstraZeneca has joined the race with its latest acquisition.

December 21, 2023 - 7 minutesmins - By Roohi Mariam Peter

News and Trends 7 Dec 2023

BIO-Europe 2023: top ten highlights

The biopharma community met at Munich in Germany for BIO-Europe 2023, where attendees from across the world took part in networking events to foster collaboration, last month. With a turnout of nearly 6000 participants and more than 150 exhibitors, the event hosted a number of panel discussions. In collaboration with our parent company, life science […]

December 7, 2023 - 24 minutesmins - By Dylan Kissane

News and Trends 6 Dec 2023

A gene editing milestone: The FDA approves CASGEVY, the first CRISPR-based therapy

Still a relatively new technology, CRISPR has been heralded in recent years as having the potential to tackle a range of diseases. And now, it has finally proved its worth. In a world first, the U.S. Food and Drug Administration (FDA) has approved CASGEVY – the CRISPR-based gene therapy developed by Vertex Pharmaceuticals and CRISPR […]

December 6, 2023 - 6 minutesmins - By Willow Shah-Neville

News and Trends 1 Dec 2023

Arvinas raises $350 million; Exonate’s trial reaps success; new cancer drugs discovered

Here is Labiotech’s weekly roundup of the latest biotech news. Stay in the loop by subscribing to our newsletter for direct updates to your inbox. The latest biotech news in fundraising In the news this week, biotech Arvinas raises $350 million PIPE American protein degradation company Arvinas has bagged $350 million in a private placement (PIPE). The […]

December 1, 2023 - 11 minutesmins - By Roohi Mariam Peter

News and Trends 20 Nov 2023

M&As: what’s up with the ADC buying spree?

Antibody drug conjugates (ADCs) have been much sought-after through investments of late, with big pharma eyeing these drugs developed by various biotechs, to eventually nab them. With yet another ADC being bought by Bristol Myers Squibb, and AbbVie’s proposed $10 billion deal to seize ImmunoGen’s oncology pipeline, are these drugs the golden ticket to targeted […]

November 20, 2023 - 7 minutesmins - By Roohi Mariam Peter

News and Trends 17 Nov 2023

With $700 million Q3 rise, U.K. biotech spearheads European recovery

The U.K.’s biotechnology landscape has witnessed an impressive surge in funding, clocking a robust £563 million ($700 million) in venture capital and public financings in the third quarter of 2023, according to Biotech Finance. This achievement marks a staggering 48% increase from the previous quarter and sets a formidable pace that is already on track […]

November 17, 2023 - 4 minutesmins - By Jules Adam

News and Trends 3 Nov 2023

BioTechX 2023: the highlights

BioTechX 2023, one of Europe’s largest conventions, that blends diagnostics, precision medicine and digital transformation in the field of healthcare, took place in the biotech hub of Basel, Switzerland. The event, which was held from October 4 to 6, hosted expert panelists who shared their knowledge on the digital transformation in pharma, leveraging artificial intelligence, […]

November 3, 2023 - 16 minutesmins - By Dylan Kissane

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us